Showing 241 - 260 results of 1,522 for search '"radiosensitivity"', query time: 0.14s Refine Results
  1. 241
  2. 242
  3. 243
  4. 244
  5. 245
  6. 246
  7. 247

    Effect and mechanism of CyPA in radiosensitization of lung adenocarcinoma using CRISPR/Cas9 technology by Jinkun Ma, Lin Xu, Jinchang Huang, Qiaoli Zhang, Yuqin Qiu, Xuewei Qi, Lina Wang, Yuchan Cao, Zeyu Liu, Shiyun Liu

    Published 2020-03-01
    “…Keywords: CyPA, Fuzhengzengxiao decoction, Gene knockout, Lung adenocarcinoma, Radiosensitization…”
    Get full text
    Article
  8. 248

    Hypoxia-Induced Cancer Cell Responses Driving Radioresistance of Hypoxic Tumors: Approaches to Targeting and Radiosensitizing by Alexander E. Kabakov, Anna O. Yakimova

    Published 2021-03-01
    “…Molecular targets for and various approaches to radiosensitizing hypoxic tumors are considered in the present review. …”
    Get full text
    Article
  9. 249

    Tyrosine Kinase c-MET as Therapeutic Target for Radiosensitization of Head and Neck Squamous Cell Carcinomas by Lina Lüttich, María José Besso, Stephan Heiden, Lydia Koi, Michael Baumann, Mechthild Krause, Anna Dubrovska, Annett Linge, Ina Kurth, Claudia Peitzsch

    Published 2021-04-01
    “…Amongst them, crizotinib, foretinib, and Pha665752 exhibited the strongest radiosensitizing effect. Kinase activity profiling showed an association of crizotinib resistance with compensatory PI3K/AKT and MAP kinase signaling. …”
    Get full text
    Article
  10. 250
  11. 251
  12. 252
  13. 253

    Telomere Length Dynamics and Chromosomal Instability for Predicting Individual Radiosensitivity and Risk via Machine Learning by Jared J. Luxton, Miles J. McKenna, Aidan M. Lewis, Lynn E. Taylor, Sameer G. Jhavar, Gregory P. Swanson, Susan M. Bailey

    Published 2021-03-01
    “…Telomeres represent a compelling biomarker of individual radiosensitivity and risk, as exposure can result in dysfunctional telomere pathologies that coincidentally overlap with many radiation-induced late effects, ranging from degenerative conditions like fibrosis and cardiovascular disease to proliferative pathologies like cancer. …”
    Get full text
    Article
  14. 254
  15. 255

    Small-molecule Polθ inhibitors provide safe and effective tumor radiosensitization in preclinical models by Rodriguez-Berriguete, G, Ranzani, M, Prevo, R, Puliyadi, R, Machado, N, Bolland, HR, Millar, V, Ebner, D, Boursier, M, Cerutti, A, Cicconi, A, Galbiati, A, Grande, D, Grinkevich, V, Majithiya, J, Piscitello, D, Rajendra, E, Stockley, M, Boulton, SJ, Heald, R, Hammond, EM, Smith, GCM, Robinson, H, Higgins, GS

    Published 2023
    “…Importantly, noncancerous cells were not radiosensitized by Polθ inhibition. Mechanistically, we show that the radiosensitization caused by Polθ inhibition is most effective in replicating cells and is due to impaired DNA damage repair. …”
    Journal article
  16. 256

    Molecular targets for altering radiosensitivity: lessons from Ras as a pre-clinical and clinical model. by Cengel, K, Mckenna, W

    Published 2005
    “…Therefore, inhibiting Ras activation represents a promising molecular approach for radiosensitization in cancer therapy.…”
    Journal article
  17. 257
  18. 258
  19. 259
  20. 260